London-based MiNA Therapeutics appointed experienced Peter Bains as its new Chief Business Officer. Bains knows the company well, as he has served on MiNA’s Board of Directors as a Non Executive Director since 2014. He will retain this position.  Bains worked more than 20 years for GlaxoSmithKline. He held leadership roles in business development, commercial and general management. Subsequently, he led Syngene International and Sosei Heptares as Chief Executive Officer.